Invited Faculty
  • Martin Perry
    NHS Greater Glasgow and Clyde
    United Kingdom
  • Dr Perry graduated MBChB from the University of Glasgow in 2000, having also completed a BSc (Hons) and subsequently MMEd (Dundee) and attained FRCP (Edin). Having trained in the West of Scotland, he took a Consultant Physician and Rheumatologist Post based at the Royal Alexandra Hospital Paisley in 2011, and became Lead Clinician for the Vale of Leven Hospital in 2014, and Specialty Advisor for Rheumatology in 2018. He was seconded to National Services as rheumatology lead for biosimilar engagement programme across Scotland for 2 years, with an interest in biologic drug level testing, helping set up a national testing service, participating in a NICE technology appraisal and EULAR task force. He has co-authored an undergraduate text on rheumatology, and recently participated in a Health Foundation funded rheumatology registry project based on the Swedish national registry
    Research & Clinical Focus

    Therapeutic Drug Monitoring of biologic therapy

    Rheumatoid arthritis

    Medical Education

  • Date Time Room Session Title Lecture Title
    Oct 21 12:00-12:40 Room B [Luncheon Symposium II - Celltrion] New Treatment Option in Rheumatic Disease Benefits of switching from IV to SC infliximab: European cases